Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GSK’s Arzerra conditionally approved in Europe

April 20, 2010
Research and Development, Sales and Marketing Arzerra, GSK, leukaemia

GlaxoSmithKline’s orphan cancer treatment Arzerra has been given conditional marketing authorisation in the European Union. Arzerra (ofatumumab) can be used …

News

Reprieve for GSK workers as NY plant closure is cancelled

April 13, 2010
Manufacturing and Production GSK

The jobs of up to 210 workers at a GlaxoSmithKline plant in New York, USA, have been saved after the …

News

GSK agrees generic deal on Malarone

April 13, 2010
Sales and Marketing GSK, depression, generics

Generic versions of two GlaxoSmithKline products have received the green light for launch in the US. Mylan has been given …

News
GSK pandemrix

UK recoups cost from unused H1N1 vaccine

April 7, 2010
Sales and Marketing GSK, NHS, h1n1

The UK government has agreed a deal with GlaxoSmithKine on surplus supplies of its H1N1 vaccine Pandemrix. The Department of …

News

GSK and Crucell to develop malaria vaccine

April 7, 2010
Sales and Marketing Crucell, GSK, malaria

GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …

News

Virus contamination found in GSK’s Rotarix

March 23, 2010
Business Services, Manufacturing and Production, Sales and Marketing Contamination, GSK, Vaccine, manufacturing compliance

The European Medicines Agency has demanded more information “as a matter of urgency” from GlaxoSmithKline over a virus in its …

News
GSK's Alli

GSK plans obesity documentary

January 29, 2010
Medical Communications Alli, GSK, obesity

Obesity is about to get the Hollywood treatment with GlaxoSmithKline Consumer Healthcare funding a documentary by Oscar-winning director Barry Levinson. …

News

In brief: European Medicines Agency news

January 26, 2010
Research and Development, Sales and Marketing Arepanrix, Arzerra, EMEA, GSK, Tysabri

GlaxoSmithKline’s influenza vaccine Arepanrix has been granted conditional marketing authorisation in Europe under an emergency fast-track procedure.It is the fourth …

News
Witty

GSK’s Andrew Witty appointed president of EFPIA

January 5, 2010
Research and Development, Sales and Marketing Andrew Witty, EFPIA, GSK, appointment, research and development, sales and marketing

GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …

Appointment

Pharma mergers and acquisitions in 2009

December 22, 2009
Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

Feature
GlaxoSmitKline's headquarters

GSK joins new NHS innovation initiative

December 22, 2009
BMW, BT, GSK, HIEC, NHS

GlaxoSmithKline, as well as less obvious names such as BMW and BT, are among the companies involved in the NHS’s …

News

GSK discloses US healthcare professional payments

December 15, 2009
Medical Communications GSK, doctors, industry reputation, payments

GlaxoSmithKline has disclosed some of the fees it has paid to US healthcare professionals for speaking and consulting services.The list …

News

GSK to invest in UK manufacturing thanks to ‘patent box’ concept

December 11, 2009
Manufacturing and Production GSK, biopharmaceutical

GlaxoSmithKline has welcomed plans for a new UK government initiative the ‘patent box’ aimed at stimulating investment in the UK.  …

News
GlaxoSmithKline's Kai Gait

Digital Pharma: A Year in Digital (2/5)

December 10, 2009
Medical Communications 2009, GSK, digi, digital pharma, year in review

Favourite use of digital (pharma)Creative Lynx & Jansen-Cilag’s Concerta XL Tablet PC campaignFavourite use of digital (non-pharma)BBC iPlayerFavourite social media …

Feature

GSK licences smoking vaccine candidate

November 30, 2009
Research and Development GSK, Nabi, smoking, vaccines

GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026